Study Registration by Pfizer Sample Clauses

The 'Study Registration by Pfizer' clause requires Pfizer to register the clinical study with appropriate public databases or registries. In practice, this means Pfizer must submit key details about the study, such as its objectives, methodology, and status, to platforms like ClinicalTrials.gov before enrolling participants. This clause ensures transparency and public accessibility of study information, helping to prevent selective reporting and promoting trust in the research process.
Study Registration by Pfizer. Pfizer commits to register, on the National Institutes of Health Clinical Trials Data Bank (▇▇▇.▇▇▇▇▇▇▇▇▇▇▇▇▇▇.▇▇▇), all Pfizer-sponsored Phase 1 through 4 interventional and non- interventional studies that involve the use of a Pfizer product and evaluate the safety or efficacy of that product. Pfizer will also register Pfizer-sponsored studies on other listings of ongoing studies maintained by competent regulatory authorities where there is a regulatory requirement to do so. 16.
View SourceView Similar (6)
Study Registration by Pfizer. Pfizer commits to register, on the National Institutes of Health Clinical Trials Data Bank (▇▇▇.▇▇▇▇▇▇▇▇▇▇▇▇▇▇.▇▇▇), all Pfizer-sponsored Phase 1 through 4 interventional and non-interventional studies that involve the use of a Pfizer product and evaluate the safety or efficacy of that product. Pfizer will also register Pfizer-sponsored studies on other listings of ongoing studies maintained by competent regulatory authorities where there is a regulatory requirement to do so. 15.5 Registrace Studie společností Pfizer. Společnost Pfizer se zavazuje zaregistrovat v databázi klinických hodnocení národních ústavů zdraví (▇▇▇.▇▇▇▇▇▇▇▇▇▇▇▇▇▇.▇▇▇) veškeré intervenční a neintervenční studie 1. až 4. fáze sponzorované společností Pfizer, v nichž se používá přípravek společnosti Pfizer a které hodnotí bezpečnost nebo účinnost tohoto přípravku. Společnost Pfizer také zaregistruje studie sponzorované společností Pfizer v registrech probíhajících studií vedených příslušnými kontrolními úřady, u nichž je registrace požadována.
View SourceView Similar (3)
Study Registration by Pfizer. Pfizer commits to register, on the National Institutes of Health Clinical Trials Data Bank (▇▇▇.▇▇▇▇▇▇▇▇▇▇▇▇▇▇.▇▇▇), all Pfizer-sponsored non- interventional studies that involve the use of a Pfizer product and evaluate the safety or efficacy of that product. Pfizer will also register Pfizer- sponsored studies on other listings of ongoing studies maintained by competent regulatory authorities where there is a regulatory requirement to do so. 15.1 Registrace studie společností Pfizer. Společnost Pfizer se zavazuje zaregistrovat všechny neintervenční studie, jejichž je zadavatelem a v rámci nichž se používá přípravek společnosti Pfizer, v databázi National Institutes of Health Clinical Trials Data Bank (▇▇▇.▇▇▇▇▇▇▇▇▇▇▇▇▇▇.▇▇▇) a vyhodnotit bezpečnost nebo účinnost tohoto přípravku. V případě existence regulačního požadavku společnost Pfizer studie, jejichž je zadavatelem, dále zapíše na jiné seznamy probíhajících studií vedené příslušnými regulačními orgány.
View SourceView Similar (2)
Study Registration by Pfizer. Pfizer commits to register, on the National Institutes of Health Clinical Trials Data Bank (▇▇▇.▇▇▇▇▇▇▇▇▇▇▇▇▇▇.▇▇▇),
View Source
Study Registration by Pfizer. Subcontractor hereby acknowledges that Pfizer will register the Study on the EU Post-Authorisation Study (PAS) Register (▇▇▇▇://▇▇▇.▇▇▇▇▇▇.▇▇/encepp/studiesDatabase.jsp).
View Source
Study Registration by Pfizer. Pfizer commits to register, on the National Institutes of Health Clinical Trials Data Bank (▇▇▇.▇▇▇▇▇▇▇▇▇▇▇▇▇▇.▇▇▇), all Pfizer- sponsored Phase 1 through 4 interventional and non- interventional studies that involve the use of a Pfizer product and 15.3 Registrace Studie společností Pfizer. Společnost Pfizer se zavazuje zaregistrovat v databázi klinických hodnocení národních ústavů zdraví (▇▇▇.▇▇▇▇▇▇▇▇▇▇▇▇▇▇.▇▇▇) veškeré intervenční a neintervenční studie 1. až 4. fáze sponzorované společností Pfizer, v nichž se evaluate the safety or efficacy of that product. Pfizer will also register Pfizer-sponsored studies on other listings of ongoing studies maintained by competent regulatory authorities where there is a regulatory requirement to do so. používá přípravek společnosti Pfizer a které hodnotí bezpečnost nebo účinnost tohoto přípravku. Společnost Pfizer také zaregistruje studie sponzorované společností Pfizer v registrech probíhajících studií vedených příslušnými kontrolními úřady, u nichž je registrace požadována.
View Source

Related to Study Registration by Pfizer

  • NERC Registration The NTO shall register or enter into agreement with a NERC registered entity for all required NERC functions applicable to the NTO, that may include, without limitation, those functions designated by NERC to be: “Transmission Owner” and “Transmission Planner” and “Transmission Operator.” The Parties agree to negotiate in good faith the compliance obligations for the NERC functions applicable to, and to be performed by, each Party with respect to the NTO’s facilities. Notwithstanding the foregoing, the ISO shall register for the “Transmission Operator” function for all NTO Transmission Facilities under ISO Operational Control identified in Appendix A-1 of this Agreement.

  • SEC Registration The Parties mutually agree to use commercially reasonable efforts to maintain effective registration statements with the Securities and Exchange Commission with respect to the long-term incentive awards to the extent any such registration statement is required by applicable Law.

  • SEC Registration and Reporting a. Assist Fund counsel in annual update of the Registration Statement. b. Prepare and file annual and semiannual shareholder reports, Form N-SAR, Form N-CSR, Form N-Q filings and Rule 24f-2 notices. As requested by the Trust, prepare and file Form N-PX filings. c. Coordinate the printing, filing and mailing of Prospectuses and shareholder reports, and amendments and supplements thereto. d. File fidelity bond under Rule 17g-1. e. Monitor sales of Fund shares and ensure that such shares are properly registered or qualified, as applicable, with the SEC and the appropriate state authorities. f. Assist Fund counsel in preparation of proxy statements and information statements, as requested by the Trust.

  • Company Registration If the Company proposes to register (including, for this purpose, a registration effected by the Company for stockholders other than the Holders) any of its securities under the Securities Act in connection with the public offering of such securities solely for cash (other than in an Excluded Registration), the Company shall, at such time, promptly give each Holder notice of such registration. Upon the request of each Holder given within twenty (20) days after such notice is given by the Company, the Company shall, subject to the provisions of Subsection 2.3, cause to be registered all of the Registrable Securities that each such Holder has requested to be included in such registration. The Company shall have the right to terminate or withdraw any registration initiated by it under this Subsection 2.2 before the effective date of such registration, whether or not any Holder has elected to include Registrable Securities in such registration. The expenses (other than Selling Expenses) of such withdrawn registration shall be borne by the Company in accordance with Subsection 2.6.

  • Registration, etc Each Pledgor agrees that, upon the occurrence and during the continuance of an Event of Default hereunder, if for any reason the Collateral Agent desires to sell any of the Pledged Securities of the Borrower at a public sale, it will, at any time and from time to time, upon the written request of the Collateral Agent, use its best efforts to take or to cause the issuer of such Pledged Securities to take such action and prepare, distribute and/or file such documents, as are required or advisable in the reasonable opinion of counsel for the Collateral Agent to permit the public sale of such Pledged Securities. Each Pledgor further agrees to indemnify, defend and hold harmless the Collateral Agent, each other Secured Party, any underwriter and their respective officers, directors, affiliates and controlling persons from and against all loss, liability, expenses, costs of counsel (including, without limitation, reasonable fees and expenses to the Collateral Agent of legal counsel), and claims (including the costs of investigation) that they may incur insofar as such loss, liability, expense or claim arises out of or is based upon any alleged untrue statement of a material fact contained in any prospectus (or any amendment or supplement thereto) or in any notification or offering circular, or arises out of or is based upon any alleged omission to state a material fact required to be stated therein or necessary to make the statements in any thereof not misleading, except insofar as the same may have been caused by any untrue statement or omission based upon information furnished in writing to such Pledgor or the issuer of such Pledged Securities by the Collateral Agent or any other Secured Party expressly for use therein. Each Pledgor further agrees, upon such written request referred to above, to use its best efforts to qualify, file or register, or cause the issuer of such Pledged Securities to qualify, file or register, any of the Pledged Securities under the Blue Sky or other securities laws of such states as may be requested by the Collateral Agent and keep effective, or cause to be kept effective, all such qualifications, filings or registrations. Each Pledgor will bear all costs and expenses of carrying out its obligations under this Section 12. Each Pledgor acknowledges that there is no adequate remedy at law for failure by it to comply with the provisions of this Section 12 and that such failure would not be adequately compensable in damages, and therefore agrees that its agreements contained in this Section 12 may be specifically enforced.